Zürcher Nachrichten - MicroVision Announces Third Quarter 2025 Results

EUR -
AED 4.183233
AFN 72.900796
ALL 91.877285
AMD 414.797448
ANG 2.039348
AOA 1045.665194
ARS 1736.794975
AUD 1.614555
AWG 2.050323
AZN 1.940938
BAM 1.955317
BBD 2.295033
BDT 140.215334
BGN 1.917554
BHD 0.429594
BIF 3432.051477
BMD 1.139068
BND 1.45584
BOB 13.964547
BRL 5.909605
BSD 1.139418
BTN 109.116023
BWP 15.516164
BYN 3.442749
BYR 22325.7403
BZD 2.291733
CAD 1.611725
CDF 2665.420428
CHF 0.943457
CLF 0.027745
CLP 1095.522249
CNY 7.646851
CNH 7.670833
COP 3814.157008
CRC 518.071915
CUC 1.139068
CUP 27.347239
CVE 110.237745
CZK 24.358299
DJF 202.909834
DKK 7.475483
DOP 67.763247
DZD 152.391449
EGP 59.13438
ERN 17.086026
ETB 184.850299
FJD 2.559772
FKP 0.85991
GBP 0.859642
GEL 2.97871
GGP 0.85991
GHS 13.234728
GIP 0.85991
GMD 83.725913
GNF 10021.522331
GTQ 8.701849
GYD 238.411056
HKD 8.934226
HNL 30.583439
HRK 7.533575
HTG 149.123132
HUF 365.202455
IDR 20405.384913
ILS 3.471949
IMP 0.85991
INR 109.142689
IQD 1492.730945
IRR 1565734.922454
ISK 136.984803
JEP 0.85991
JMD 180.27543
JOD 0.807645
JPY 179.158416
KES 147.67349
KGS 99.609484
KHR 4633.85435
KMF 493.217009
KPW 1025.161906
KRW 1543.648431
KWD 0.351563
KYD 0.949565
KZT 504.7852
LAK 25558.681004
LBP 102039.372314
LKR 376.226984
LRD 195.991544
LSL 18.590804
LTL 3.363373
LVL 0.689012
LYD 7.285199
MAD 10.934597
MDL 20.225999
MGA 5030.756222
MKD 61.55978
MMK 2391.317037
MNT 4096.276898
MOP 9.206124
MRU 45.840667
MUR 54.140351
MVR 17.599037
MWK 1975.811511
MXN 20.137822
MYR 4.640683
MZN 72.79829
NAD 18.590804
NGN 1510.837951
NIO 41.929634
NOK 10.830092
NPR 174.585836
NZD 1.992947
OMR 0.439191
PAB 1.139418
PEN 3.868244
PGK 5.076745
PHP 71.01754
PKR 315.746636
PLN 4.37146
PYG 6716.339487
QAR 4.153473
RON 5.27298
RSD 117.420969
RUB 96.076247
RWF 1684.083636
SAR 4.274755
SBD 9.11313
SCR 15.836085
SDG 685.153819
SEK 11.296996
SGD 1.45562
SHP 0.859999
SLE 28.078458
SLL 23885.685201
SOS 651.238991
SRD 42.905863
STD 23576.41575
STN 24.493944
SVC 9.970535
SYP 14810.167401
SZL 18.586405
THB 38.01645
TJS 10.511601
TMT 3.99813
TND 3.373266
TOP 2.742603
TRY 55.748859
TTD 7.750084
TWD 36.141163
TZS 3024.152324
UAH 51.024285
UGX 4462.896617
USD 1.139068
UYU 45.648714
UZS 13485.665874
VES 970.977713
VND 29588.440307
VUV 134.85231
WST 3.127566
XAF 655.957
XAG 0.017716
XAU 0.000265798393
XCD 3.07839
XCG 2.053592
XDR 0.80538
XOF 655.957
XPF 119.331742
YER 269.560946
ZAR 18.57165
ZMK 10252.986409
ZMW 22.227505
ZWL 366.779554
SSP 6507.03282
MXV 2.282055
  • RIO

    0.0900

    94.56

    +0.1%

  • AZN

    2.0200

    166.58

    +1.21%

  • BTI

    -0.3900

    55.63

    -0.7%

  • NGG

    0.2600

    75.49

    +0.34%

  • GSK

    -0.4100

    49.24

    -0.83%

  • BCE

    -0.3300

    20.97

    -1.57%

  • RBGPF

    -0.5900

    65.4

    -0.9%

  • RYCEF

    -0.3600

    19.31

    -1.86%

  • CMSD

    -0.0700

    20.3

    -0.34%

  • CMSC

    -0.1100

    20.4

    -0.54%

  • BCC

    1.0400

    77.14

    +1.35%

  • RELX

    0.0100

    33.52

    +0.03%

  • BP

    -0.2600

    44.15

    -0.59%

  • VOD

    0.1300

    16.62

    +0.78%

  • JRI

    -0.1500

    11.02

    -1.36%

MicroVision Announces Third Quarter 2025 Results
MicroVision Announces Third Quarter 2025 Results

MicroVision Announces Third Quarter 2025 Results

REDMOND, WASHINGTON / ACCESS Newswire / November 11, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced its third quarter 2025 results.

Text size:

Key Business and Operational Highlights

  • Appointed 30-year industry veteran Glen DeVos as Chief Executive Officer, elevating automotive capabilities.

  • Introduced next generation solid-state lidar sensor, MOVIA S, offering an energy-efficient and cost-effective short-range solution for a wide variety of automotive, industrial, and defense sector applications.

  • Launched industry-disrupting Tri-Lidar Architecture solution, offering an alternative to the lidar industry's myopic focus on single sensor solutions.

  • Executed agreement to acquire Scantinel Photonics, a German developer of long-range FMCW lidar, joining investment and strategic partners in advancing lidar-on-chip solution for commercial vehicle and passenger car markets.

  • Established design office and testing facilities in D.C. area, with engineering expertise in aviation and avionics, accelerating development and time-to-market in defense sector, focused on intelligence, surveillance, and reconnaissance, or ISR, capabilities.

  • Expanded global sales and engineering leadership, bringing decades of experience to sales organization and commercialization discipline.

  • Maintained strong balance sheet, cost-efficient operations, and sound financial practices.

"I've been thrilled to see the Company's momentum and energy these past six weeks, as I stepped into my new role here at MicroVision," said Glen DeVos, MicroVision's Chief Executive Officer. "The Company is making great strides - processing the high level of external interest stemming from the unveiling at IAA Mobility of our next-gen short-range sensor; optimizing perception system value to automotive OEMs by disrupting norms to offer a cost-effective, integrated solution; accelerating our drone-agnostic perception solution and expansion into ISR applications; and collaborating with the EU's photonics ecosystem to bring 1550nm FMCW lidar technology to the commercial vehicle and passenger car markets."

"Based on my experience in the evolution of radar, I'm confident that MicroVision will be a leader in lidar, driving the market to a similar inflection point as we saw when radar became a standard feature in automotive ADAS," continued DeVos. "MicroVision has the product portfolio, engineering excellence, and strategic plan to disrupt the market and I am thrilled to lead MicroVision as we redefine the future of lidar."

Key Financial Highlights for Q3 2025

  • Revenue for the third quarter of 2025 was $0.2 million, flat compared to $0.2 million for the third quarter of 2024, comprised of sales to industrial customers.

  • Total operating expenses for the third quarter of 2025 were $12.0 million, which, after adjusting for non-cash items, remained relatively flat year over year as compared to $15.3 million for the third quarter of 2024.

  • Net loss for the third quarter of 2025 was $14.2 million, or $0.05 per share, which includes $2.2 million of non-cash interest expense related to financings, $1.2 million of severance payments related to CEO transition, $0.7 million related to non-cash unrealized gains on warrants and derivatives, and a negative $1.6 million of non-cash share-based compensation expense (which was negative due to the reversal of expense in connection with the forfeiture of certain executive awards in the period), compared to a net loss of $15.5 million, or $0.07 per share, which includes $2.4 million of non-cash share-based compensation expense for the third quarter of 2024.

  • Adjusted EBITDA for the third quarter of 2025 was a $11.7 million loss, flat compared to a $11.7 million loss for the third quarter of 2024.

  • Cash used in operations in the third quarter of 2025 was $16.5 million, compared to cash used in operations in the third quarter of 2024 of $14.1 million.

  • The Company ended the third quarter of 2025 with $99.5 million in cash and cash equivalents, including investment securities, compared to $74.7 million as of December 31, 2024.

As of September 30, 2025, the Company has access to $76.2 million of additional capital, subject to certain conditions, including $46.2 million under its existing ATM, or at-the-market, facility and $30 million from the remaining commitment pursuant to the convertible note facility.

Conference Call and Webcast: Q3 2025 Results

MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Tuesday, November 11, 2025 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on November 11, 2025 and may submit questions HERE in advance of the conference call.

The live webcast can be accessed on the Company's Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing.

About MicroVision

MicroVision is at the forefront of driving the global adoption of innovative perception solutions, with the goal of making mobility and autonomy safer. Our engineering excellence, based in Washington State, Washington D.C., and Hamburg, Germany enables us to develop and supply integrated lidar hardware and perception software solutions. Our proprietary technologies enhance safety and automation across various industrial applications, including robotics, automated warehouses, and agriculture, and are instrumental in the development of autonomous systems. MicroVision's core technology, initially developed for the automotive industry, continues to accelerate advanced driver-assistance systems (ADAS) and autonomous driving. Building on our history of providing technology to the military segment, our target offerings include semi- and fully autonomous airborne and terrestrial sensor systems. With our solid-state lidar technologies, encompassing MEMS-based long-range lidar and flash-based short-range lidar, integrated with our onboard perception software, MicroVision possesses the expertise to deliver safe mobility at the speed of life.

For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.

MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Non-GAAP information

To supplement MicroVision's condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures "adjusted EBITDA" and "adjusted Gross Profit." Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; and restructuring costs. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision's past financial reports, and facilitates comparisons with other companies in the Company's industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company's operating results and facilitates comparisons of the Company's core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision's operating performance and the valuation of the Company.

Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision's business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.

Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

Forward-Looking Statements

Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for revenue and cash; expense reduction; market position; product portfolio; product and manufacturing capabilities; transaction benefits, conditions, and expected completion; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor Relations Contact
Jeff Christensen
Darrow Associates Investor Relations
[email protected]

Media Contact
[email protected]

MicroVision, Inc.
Consolidated Balance Sheets
(In thousands)

September 30,

December 31,

2025

2024

Assets
Current assets
Cash and cash equivalents

$

72,832

$

54,486

Investment securities, available-for-sale

26,676

20,216

Restricted cash, current

328

261

Accounts receivable, net of allowances

40

926

Inventory

8,131

2,294

Other current assets

6,969

4,287

Total current assets

114,976

82,470

Property and equipment, net

6,574

7,061

Operating lease right-of-use assets

15,365

16,746

Restricted cash, net of current portion

1,374

1,500

Intangible assets, net

10,281

10,972

Other assets

2,252

2,412

Total assets

$

150,822

$

121,161

Liabilities and shareholders' equity
Current liabilities
Accounts payable

$

1,339

$

1,132

Accrued liabilities

3,754

2,542

Contract liabilities

147

308

Derivative liability

1,856

14,581

Notes payable, current

28,963

24,248

Operating lease liabilities, current

3,154

2,682

Finance lease liabilities, current

14

-

Other current liabilities

672

458

Total current liabilities

39,899

45,951

Notes payable, net of current portion

-

8,754

Warrant liability

4,059

-

Operating lease liabilities, net of current portion

14,434

15,954

Finance lease liabilities, net of current portion

31

-

Other long-term liabilities

1,680

1,733

Total liabilities

60,103

72,392

Commitments and contingencies
Shareholders' equity
Common stock at par value

302

225

Additional paid-in capital

1,009,272

910,825

Accumulated other comprehensive income

651

-

Accumulated deficit

(919,506

)

(862,281

)

Total shareholders' equity

90,719

48,769

Total liabilities and shareholders' equity

$

150,822

$

121,161

MicroVision, Inc.
Consolidated Statement of Operations
(In thousands, except per share data)

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Revenue

$

241

$

190

$

985

$

3,046

Cost of revenue

957

583

2,223

3,414

Gross loss

(716

)

(393

)

(1,238

)

(368

)

Research and development expense

7,978

8,736

23,039

40,251

Sales, marketing, general and administrative expense

4,027

6,599

17,140

23,423

Impairment loss on intangible assets

-

-

-

3,027

Gain on disposal of fixed assets

-

(22

)

-

(22

)

Total operating expenses

12,005

15,313

40,179

66,679

Loss from operations

(12,721

)

(15,706

)

(41,417

)

(67,047

)

Interest expense

(2,197

)

(21

)

(17,270

)

(51

)

Unrealized gain on derivative liability

1,059

-

3,853

-

Unrealized (loss) gain on warrant liability

(326

)

-

2,238

-

Realized loss on debt extinguishment

-

-

(4,654

)

-

Other income

140

318

363

1,764

Net loss before taxes

$

(14,045

)

$

(15,409

)

$

(56,887

)

$

(65,334

)

Income tax expense

(172

)

(108

)

(338

)

(426

)

Net loss

$

(14,217

)

$

(15,517

)

$

(57,225

)

$

(65,760

)

Net loss per share - basic and diluted

(0.05

)

$

(0.07

)

$

(0.22

)

$

(0.32

)

Weighted-average shares outstanding - basic and diluted

295,461

213,004

262,235

206,164

MicroVision, Inc.
Consolidated Statements of Cash Flows
(In thousands)

Nine months ended September 30,

2025

2024

Cash flows from operating activities
Net loss

$

(57,225

)

$

(65,760

)

Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization

4,347

5,246

Gain on disposal of fixed assets

-

(22

)

Impairment of intangible assets

-

3,027

Impairment of operating lease right-of-use assets

-

406

Unrealized gain on derivative liability

(3,853

)

-

Unrealized gain on warrant liability

(2,238

)

-

Loss on debt extinguishment

4,654

-

Inventory write-downs

-

127

Non-cash interest expense

7,325

-

Amortization of debt discount and issuance costs on notes payable

9,915

-

Share-based compensation expense

2,248

9,522

Net accretion of premium on short-term investments

(284

)

(776

)

Change in:
Accounts receivable

886

717

Inventory

(5,798

)

(723

)

Other current and non-current assets

(2,170

)

606

Accounts payable

207

(784

)

Accrued liabilities

1,087

(2,747

)

Contract liabilities and other current liabilities

32

109

Operating lease liabilities

(2,188

)

(1,944

)

Other long-term liabilities

(260

)

(488

)

Net cash used in operating activities

(43,315

)

(53,484

)

Cash flows from investing activities
Sales of investment securities

26,688

28,311

Purchases of investment securities

(32,878

)

(25,570

)

Purchases of property and equipment

(435

)

(271

)

Cash paid for Ibeo business combination

-

(6,300

)

Net cash used in investing activities

(6,625

)

(3,830

)

Cash flows from financing activities
Principal payments under finance leases

(10

)

-

Principal payments under notes payable

(5,500

)

-

Proceeds from stock option exercises

-

62

Net proceeds from issuance of common stock and warrants

73,268

26,093

Net cash provided by financing activities

67,758

26,155

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

469

133

Change in cash, cash equivalents, and restricted cash

18,287

(31,026

)

Cash, cash equivalents, and restricted cash at beginning of period

56,247

49,391

Cash, cash equivalents, and restricted cash at end of period

$

74,534

$

18,365

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of September 30, 2025 and 2024:

September 30,

September 30,

2025

2024

Cash and cash equivalents

$

72,832

$

16,523

Restricted cash, current

328

270

Restricted cash, net of current portion

1,374

1,572

Cash, cash equivalents, and restricted cash

$

74,534

$

18,365

MicroVision, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands)

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Reconciliation of Non-GAAP Gross (Loss) Profit:
Gross loss

$

(716

)

$

(393

)

$

(1,238

)

$

(368

)

Share-based compensation expense

-

-

-

-

Amortization of acquired intangibles

290

361

652

1,135

Adjusted Gross (Loss) Profit

$

(426

)

$

(32

)

$

(586

)

$

767

Reconciliation of Non-GAAP Loss:
GAAP Net loss

$

(14,217

)

$

(15,517

)

$

(57,225

)

$

(65,760

)

Interest expense, net

2,057

(462

)

16,907

(1,570

)

Income taxes

172

108

338

426

Depreciation and amortization

1,395

1,676

4,347

5,246

Unrealized gain on derivative liability

(1,059

)

-

(3,853

)

-

Unrealized loss (gain) warrant liability

326

-

(2,238

)

-

Loss on debt extinguishment

-

-

4,654

-

Impairment loss on intangible assets

-

-

-

3,027

Impairment of operating lease right-of-use assets

-

13

-

406

Share-based compensation expense

(1,603

)

2,426

2,248

9,522

Restructuring costs

-

90

-

5,804

Severance expense

1,202

-

1,202

-

Adjusted EBITDA

$

(11,727

)

$

(11,666

)

$

(33,620

)

$

(42,899

)

SOURCE: MicroVision, Inc



View the original press release on ACCESS Newswire

T.Furrer--NZN